Document Detail


BIOCLAIMS standard diet (BIOsd): a reference diet for nutritional physiology.
MedLine Citation:
PMID:  22228221     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Experimental replication is fundamental for practicing science. To reduce variability, it is essential to control sources of variation as much as possible. Diet is an important factor that can influence many processes and functional outcomes in studies performed with rodent models. This is especially true for, but not limited to, nutritional studies. To compare functional effects of different nutrients, it is important to use standardized, semi-purified diets. Here, we propose and describe a standard reference diet, the BIOCLAIMS standard diet. The diet is AIN-93 based, but further defined with dietary and experimental requirements taken into account that allow for experiments with bioactive food components and natural (non-expensive) labeling. This diet will be implemented by two European research consortia, Mitofood and BIOCLAIMS, to ensure inter-laboratory comparability.
Authors:
Femke P M Hoevenaars; Evert M van Schothorst; Olga Horakova; Anja Voigt; Martin Rossmeisl; Catalina Pico; Antoni Caimari; Jan Kopecky; Susanne Klaus; Jaap Keijer
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-7
Journal Detail:
Title:  Genes & nutrition     Volume:  -     ISSN:  1555-8932     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101280108     Medline TA:  Genes Nutr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Human and Animal Physiology, Wageningen University, Wageningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.
Next Document:  Enhanced expression of lipogenic genes may contribute to hyperglycemia and alterations in plasma lip...